Insights Into Moderna (MRNA) Q4: Wall Street Projections for Key Metrics

Analysts on Wall Street project that Moderna (MRNA) will announce quarterly loss of $2.65 per share in its forthcoming report, representing a decline of 581.8$956.11 million, declining 66% from the same quarter last year.The current level reflects an upward revision of 7.2% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over thi ...